AKT1 and Alzheimer disease: Abnormal insulin signaling leads to impairment of the PI3K/Akt signaling pathway, causing oxidative stress, impaired energy metabolism, neuroinflammation, mitochondrial dysfunction, autophagy dysfunction, and neurogenic death, all of which promote the development of AD and exacerbate cognitive dysfunction.